Skip to main content
. 2019 Jun 10;20(11):2823. doi: 10.3390/ijms20112823
AML acute myeloid leukemia
cHL classical Hodgkin´s lymphoma
CMML chronic myelomonocytic leukemia
DLBCL diffuse large B-cell lymphoma
FLT3 Fms-like tyrosine kinase 3
FLT3-ITD FLT3 with internal tandem duplications
HMAs hypomethylating agents
IHC immunohistochemistry
MDS myelodysplastic syndrome
MFI mean fluorescence intensity
MGUS monoclonal gammopathy of undetermined significance
MM multiple myeloma
NPM nucleophosmin
PD-L1 programmed death ligand-1
SSC side scatter
TILs tumor-infiltrating lymphocytes